Related Experiment Video
Updated: Jul 6, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
[Severe pulmonary hypertension and Takayasu arteritis]
Ignasi Garcia-Olivé1, Maria Sol Prats Bardají, Susana Calvo Pascual
1Servei de Pneumologia, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain. 38826igo@comb.es
Takayasu arteritis, a large vessel inflammatory disease, rarely presents with pulmonary hypertension. This case highlights successful treatment with corticosteroids, immunosuppressants, and pulmonary artery stenting.
Area of Science:
- Cardiology
- Rheumatology
- Vascular Medicine
Background:
- Takayasu arteritis is a rare, chronic inflammatory condition affecting large arteries, primarily the aorta and its branches.
- Clinical manifestations vary based on affected vessels; pulmonary artery involvement is infrequent as the primary presentation.
Observation:
- A young woman presented with dyspnea due to severe pulmonary hypertension.
- The pulmonary hypertension was diagnosed as secondary to Takayasu arteritis affecting the pulmonary artery.
Findings:
- The patient received methylprednisolone (corticosteroid) and azathioprine (immunosuppressant) therapy.
- A stent was successfully implanted in the left pulmonary artery, improving blood flow.
Implications:
- This case demonstrates that Takayasu arteritis can be the primary cause of pulmonary hypertension.
- Combined medical and interventional treatment (stenting) can effectively manage severe pulmonary hypertension in Takayasu arteritis.
- Highlights the importance of considering Takayasu arteritis in young patients with unexplained pulmonary hypertension.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...

